Thermo Fisher Scientific Pre-Tax Profit Margin 2010-2024 | TMO
Current and historical pre-tax profit margin for Thermo Fisher Scientific (TMO) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Thermo Fisher Scientific pre-tax profit margin for the three months ending September 30, 2024 was .
| Thermo Fisher Scientific Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $42.37B | $6.84B | 16.13% |
| 2024-06-30 | $42.35B | $6.86B | 16.20% |
| 2024-03-31 | $42.49B | $6.52B | 15.35% |
| 2023-12-31 | $42.86B | $6.30B | 14.70% |
| 2023-09-30 | $43.42B | $6.34B | 14.59% |
| 2023-06-30 | $43.52B | $6.17B | 14.18% |
| 2023-03-31 | $43.81B | $6.66B | 15.20% |
| 2022-12-31 | $44.92B | $7.84B | 17.44% |
| 2022-09-30 | $44.17B | $7.92B | 17.93% |
| 2022-06-30 | $42.82B | $8.50B | 19.84% |
| 2022-03-31 | $41.12B | $8.63B | 20.98% |
| 2021-12-31 | $39.21B | $8.84B | 22.55% |
| 2021-09-30 | $39.06B | $9.88B | 25.28% |
| 2021-06-30 | $38.25B | $9.95B | 26.02% |
| 2021-03-31 | $35.89B | $9.16B | 25.51% |
| 2020-12-31 | $32.22B | $7.23B | 22.44% |
| 2020-09-30 | $28.50B | $5.37B | 18.85% |
| 2020-06-30 | $26.25B | $3.94B | 15.02% |
| 2020-03-31 | $25.65B | $4.08B | 15.92% |
| 2019-12-31 | $25.54B | $4.07B | 15.94% |
| 2019-09-30 | $25.22B | $4.04B | 16.03% |
| 2019-06-30 | $24.87B | $4.03B | 16.21% |
| 2019-03-31 | $24.63B | $3.45B | 13.99% |
| 2018-12-31 | $24.36B | $3.26B | 13.39% |
| 2018-09-30 | $23.90B | $3.07B | 12.85% |
| 2018-06-30 | $23.09B | $2.74B | 11.86% |
| 2018-03-31 | $22.01B | $2.56B | 11.63% |
| 2017-12-31 | $20.92B | $2.43B | 11.61% |
| 2017-09-30 | $19.82B | $2.26B | 11.41% |
| 2017-06-30 | $19.20B | $2.21B | 11.51% |
| 2017-03-31 | $18.74B | $2.10B | 11.22% |
| 2016-12-31 | $18.27B | $2.02B | 11.08% |
| 2016-09-30 | $17.97B | $1.95B | 10.87% |
| 2016-06-30 | $17.61B | $1.99B | 11.33% |
| 2016-03-31 | $17.34B | $1.98B | 11.40% |
| 2015-12-31 | $16.97B | $1.94B | 11.41% |
| 2015-09-30 | $16.81B | $1.89B | 11.25% |
| 2015-06-30 | $16.85B | $1.96B | 11.64% |
| 2015-03-31 | $16.91B | $1.70B | 10.03% |
| 2014-12-31 | $16.89B | $2.09B | 12.36% |
| 2014-09-30 | $15.86B | $1.93B | 12.15% |
| 2014-06-30 | $14.89B | $1.71B | 11.47% |
| 2014-03-31 | $13.80B | $1.75B | 12.69% |
| 2013-12-31 | $13.09B | $1.32B | 10.08% |
| 2013-09-30 | $12.88B | $1.29B | 9.98% |
| 2013-06-30 | $12.78B | $1.26B | 9.88% |
| 2013-03-31 | $12.65B | $1.30B | 10.29% |
| 2012-12-31 | $12.51B | $1.27B | 10.14% |
| 2012-09-30 | $12.30B | $1.24B | 10.06% |
| 2012-06-30 | $12.15B | $1.21B | 9.94% |
| 2012-03-31 | $11.90B | $1.15B | 9.63% |
| 2011-12-31 | $11.56B | $1.13B | 9.80% |
| 2011-09-30 | $11.05B | $1.10B | 9.95% |
| 2011-06-30 | $10.75B | $1.12B | 10.43% |
| 2011-03-31 | $10.49B | $1.13B | 10.75% |
| 2010-12-31 | $10.39B | $1.09B | 10.47% |
| 2010-09-30 | $10.49B | $1.04B | 9.93% |
| 2010-06-30 | $10.40B | $1.00B | 9.64% |
| 2010-03-31 | $10.28B | $0.97B | 9.46% |
| 2009-12-31 | $9.91B | $0.88B | 8.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $202.480B | $42.857B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $196.045B | 102.50 |
| Alcon (ALC) | Switzerland | $42.794B | 28.63 |
| Edwards Lifesciences (EW) | United States | $42.188B | 26.79 |
| IQVIA Holdings (IQV) | United States | $36.777B | 20.26 |
| IDEXX Laboratories (IDXX) | United States | $35.676B | 42.01 |
| DexCom (DXCM) | United States | $30.357B | 45.72 |
| Waters (WAT) | United States | $22.803B | 33.72 |
| STERIS (STE) | Ireland | $21.310B | 24.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.157B | 0.00 |
| Hologic (HOLX) | United States | $17.098B | 18.47 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.119B | 14.49 |
| Sysmex ADR (SSMXY) | Japan | $13.255B | 0.00 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.105B | 89.18 |
| Masimo (MASI) | United States | $9.091B | 43.99 |
| Teleflex (TFX) | United States | $8.576B | 13.68 |
| Glaukos (GKOS) | United States | $7.735B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.949B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.675B | 26.50 |
| Veracyte (VCYT) | United States | $3.420B | 102.63 |
| Inari Medical (NARI) | United States | $2.990B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.699B | 15.58 |
| Nihon Kohden (NHNKY) | Japan | $2.361B | 17.93 |
| TransMedics (TMDX) | United States | $2.291B | 72.62 |
| Elekta AB (EKTAY) | Sweden | $2.165B | 19.47 |
| Tandem Diabetes Care (TNDM) | United States | $1.978B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.739B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.365B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.39 |
| Pulse Biosciences (PLSE) | United States | $1.215B | 0.00 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.849B | 14.43 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.687B | 37.11 |
| Mesa Laboratories (MLAB) | United States | $0.674B | 15.88 |
| AxoGen (AXGN) | United States | $0.656B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.512B | 30.12 |
| Treace Medical Concepts (TMCI) | United States | $0.494B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.439B | 23.75 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| CVRx (CVRX) | United States | $0.327B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.174B | 0.00 |
| Nevro (NVRO) | United States | $0.157B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.49 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.095B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| 908 Devices (MASS) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |